2seventy bio Inc.

NASDAQ: TSVT · Real-Time Price · USD
5.00
0.00 (0.00%)
At close: May 12, 2025, 3:59 PM

2seventy bio Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-4.09M -57.25M -94.55M -156.25M -223.22M -217.57M -183.89M -180.13M -215.46M -254.15M -291.99M -284.11M -290.73M -292.21M -308.04M -320.11M -221.69M
Depreciation & Amortization
6.63M 7.1M 8.47M 9.57M 10.14M 10.29M 9.58M 9.2M 10.26M 11.53M 12.74M 15.03M 16.2M 16.35M 16.13M 14.8M 13.6M
Stock-Based Compensation
9.69M 12.15M 14.66M 21.82M 27.18M 32.16M 36.61M 39.02M 40.97M 41.04M 45.96M 44.98M 47.26M 54.63M 52.74M 56.77M 61.45M
Other Working Capital
-10.05M 7.4M -17.41M 16.76M 21.71M 3.03M -26.35M -61.38M -47M -36.2M -7.03M 7.06M 7.52M 13.34M 37.18M 21.79M -9.18M
Other Non-Cash Items
-52.74M -50M -50.52M -39.61M 8.79M 5.66M 6.42M -3.58M -2.09M 317K 1.41M 1.57M 1.71M 869K -169K -916K -3.26M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
-13.58M 3M -17.19M 14.34M 17.47M 2.6M -27.46M -62.66M -45.83M -35.87M -7.22M 1.01M 9.21M 13.33M 35.9M 26.47M -7.12M
Operating Cash Flow
-54.09M -85M -139.12M -150.13M -159.65M -166.86M -158.74M -198.16M -212.16M -237.13M -239.09M -221.51M -216.35M -207.03M -203.42M -222.99M -157.02M
Capital Expenditures
-95K -707K -1.78M -4.49M -8.4M -13.87M -15.96M -26.63M -25.34M -22.84M -20.65M -15.86M -16.81M -19.57M -25.6M -20.65M -22.82M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a -2.63M 66.24M 66.24M 66.24M 68.87M n/a n/a n/a n/a n/a n/a
Purchase of Investments
-110.9M -127.47M -114.04M -112.63M -227.22M -246.74M -267.37M -278.98M -159.55M -145.91M -115.69M -22.45M -22.45M n/a n/a n/a n/a
Sales Maturities Of Investments
158.5M 166.5M 181.5M 239.92M 257.92M 304.9M 278.75M 202.7M 196.64M 180.45M 182.58M 158.21M 105.77M 34.99M n/a n/a n/a
Other Investing Acitivies
51.05M 42.43M 40.98M 41.41M -1.41M -430K 2.65M -66.22M -13.77M 34.57M 66.92M 129.79M 75.32M 26.99M -8M -2M n/a
Investing Cash Flow
98.56M 80.76M 106.66M 164.22M 20.9M 43.86M -4.56M -102.91M 11.75M 11.7M 46.24M 119.91M 66.51M 15.41M -25.6M -20.65M -22.82M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a 75K n/a n/a n/a -75K n/a -4.28M -4.28M -4.28M -4.28M n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
531K 417K 667K 615K 838K 602K 579K 777K 747K 696K 187.16M 238.94M 283.89M 354.89M 229.03M 243.63M 179.83M
Financial Cash Flow
531K 417K 667K 540K 692K 127.39M 127.37M 127.62M 123.21M 166.23M 352.69M 404.49M 453.89M 354.89M 229.03M 243.63M 179.83M
Net Cash Flow
44.99M -3.82M -31.6M 14.81M -137.88M 4.58M -35.94M -173.45M -77.2M -59.21M 159.84M 302.88M 304.05M 163.27M n/a n/a n/a
Free Cash Flow
-54.19M -85.7M -140.9M -154.61M -168.04M -180.72M -174.7M -224.79M -237.49M -259.98M -259.74M -237.37M -233.16M -226.61M -229.03M -243.63M -179.83M